PRE PRENETICS GLOBAL LIMITED

Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market

Prenetics’ IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market

Adds Renowned Clinical Experts Dr. Jeremy London and Dr. Amy Shah to Existing Team from Mayo Clinic, Cedars-Sinai, NASA and Yale University

CHARLOTTE, N.C., March 18, 2025 (GLOBE NEWSWIRE) --  , the premium supplements brand co-founded by David Beckham, today announced the addition of two distinguished new members, Dr. Jeremy London and Dr. Amy Shah, to its world-class (SAB). These additions underscore IM8’s unwavering commitment to leading innovation in science, longevity and human performance.

Newly joining IM8’s SAB are:

Dr. Amy Shah – An acclaimed integrative medicine physician and double board-certified expert in Internal Medicine, Dr. Shah focuses on gut health, hormonal balance and nutrition. Her practical, evidence-based approach and extensive experience in integrative wellness will guide IM8’s continued development of comprehensive wellness solutions.

Dr. Jeremy London – With over 25 years of experience, Dr. London is a board-certified and renowned cardiothoracic surgeon specializing in preventive cardiovascular health. He is recognized as a leader in minimally invasive heart valve treatments and thoracic aortic aneurysm repair. Dr. London’s deep commitment to preventive care and patient education will further enhance IM8’s cardiovascular health product initiatives.

“Our Scientific Advisory Board has been instrumental since day one in helping us set industry-leading standards," said Danny Yeung, co-founding partner and CEO of IM8. “We’re eager to welcome Dr. Jeremy London and Dr. Amy Shah, whose exceptional expertise will elevate our innovative research and product development even further, reinforcing IM8’s position as a trusted leader in health and wellness.”

Since its inception, IM8’s SAB has featured top experts whose contributions have been crucial to the company’s product development. Among those experts include:

Dr. Dawn Mussallem – Integrative Oncologist at Mayo Clinic

Dr. Mussallem is a distinguished consultant in the Division of Hematology Oncology at Mayo Clinic, where she has served as a clinician for over 20 years, and an Assistant Professor of Medicine. She is a double board-certified lifestyle medicine breast specialist at The Robert and Monica Jacoby Center for Breast Health and founded the Integrative Medicine and Breast Health Program at Mayo Clinic Florida.

Dr. Jim Green – Former Chief Scientist of NASA

Dr. Green has led numerous groundbreaking NASA missions, including Mars Rover landings and the New Horizons mission to Pluto. His expertise in space science and biomedical innovations uniquely benefits IM8’s approach to health and longevity.

Dr. James DiNicolantonio – Cardiovascular Research Scientist and Author

Dr. DiNicolantonio is widely recognized for his research on nutrition, metabolism and human health. He is known for translating complex nutritional science into actionable health advice, strengthening IM8’s nutritional offerings. He is the author/co-author of over 250 academic publications in the medical literature spanning nutrition, nutraceuticals, cardiovascular health, longevity and overall health.

Dr. Suzanne Devkota – Director of Microbiome Research Lab at Cedars-Sinai Medical Center

Dr. Devkota’s pioneering research in microbiome science and its role in chronic diseases aligns closely with IM8’s commitment to developing innovative gut-health solutions. With over 15 years of experience in the field, Dr. Devkota’s research emphasizes the critical connection between the microbiome and overall health, highlighting the potential for microbiome-based therapies.

Dr. David Katz – Founding Director of Yale-Griffin Prevention Research Center

Dr. Katz is an internationally recognized expert in preventive medicine, nutrition and public health. His contributions have significantly influenced IM8’s scientifically-validated nutrition and preventive healthcare solutions. He has roughly 250 peer-reviewed publications and has authored/co-authored 19 books to date including multiple editions of leading textbooks in nutrition, preventive medicine, and epidemiology.

Dr. Stephen Anton – Professor in the Department of Physiology and Aging at University of Florida

Prof. Stephen Anton is a renowned expert in aging and metabolic health, with over 20 years of experience in the field. He is a Distinguished Professor at the University of Florida with a primary appointment in the Department of Physiology and Aging. Prof. Anton’s research focuses on the interplay between lifestyle factors, metabolic health, and aging, with a particular emphasis on the benefits of caloric restriction, intermittent fasting, and physical activity.

IM8’s flagship product, , exemplifies the SAB’s foundational role. This clinically-validated all-in-one daily powder supplement is designed to replace up to 16 supplements, enhancing energy, immunity, digestion and longevity. Supported by rigorous clinical trials and third-party NSF certification for Sport, it demonstrates IM8’s dedication to quality, transparency and efficacy.

The global supplements market is valued at by 2028, driven by growing consumer demand for credible, scientifically-backed products.

About IM8

IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8’s flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a subsidiary of Prenetics, a leading global health sciences company dedicated to advancing consumer health.

Media Contact

Camille Livesay

Jack Taylor Public Relations



EN
18/03/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PRENETICS GLOBAL LIMITED

 PRESS RELEASE

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics’ IM8 Health as...

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder Aryna Sabalenka becomes first-ever current athlete shareholder in Prenetics, listed on the NASDAQ: (PRE)In just six months, IM8 is one of the fastest growing supplement brands in the world, generating an extraordinary US$50m+ Annual Recurring RevenueIM8 has built a loyal customer base of 60,000+ users who have consumed over 5 million servingsIM8, co-founded by David Beckham is available at CHARLOTTE, N.C., June 26, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a le...

 PRESS RELEASE

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitco...

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board -  Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy's ~$40B Bitcoin holdings and Metaplanet's meteoric treasury transformation -  Following strategic divestiture, Prenetics leverages strengthened $117M balance sheet to execute comprehensive Bitcoin strategy with board-approved majority allocation, institutional financing partnerships, and alpha-generating initiatives. CHARLOTTE, N.C., June 18, 2025 (GLO...

 PRESS RELEASE

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to U...

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction Bolsters Prenetics’ pro-forma cash reserves to approximately US$86 million, and pro-forma cash and short-term assets to approximately US$117 millionPrenetics simplifies investment thesis as company focuses on high-growth consumer health brands IM8, CircleDNA, and EuropaPrenetics raised its FY2025 outlook to be US$80 – US$100 million from $73 – US$85 million, driven by the growth of IM8 CHARLOTTE, N.C., June 18, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics”), a ...

 PRESS RELEASE

Prenetics Announces First Quarter 2025 Financial Results, Raises FY202...

Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon Revenue grew 336.5% to $14.4 million from prior year (excluding ACT Genomics)Raises full year revenue outlook to $80 - $100 million (excluding ACT Genomics)IM8 contributed $5.7 million in Q1, with $2.8 million in March alone & provides Q2 revenue projectionsIM8 has more than 55,000 customers with 4.9 million servings delivered and countingDetails of crypto strategy and Bitcoin adoption to be announced soon as part of innovative treasury approach CHARLOTTE, N.C., Ju...

 PRESS RELEASE

IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studde...

IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event David Beckham was Joined by Dr. Amy Shah, Dr. Jeremy London, Dr. James DiNicolantonio and Kendal Toole to Reinforce IM8’s Vision for Elite Wellness Accessible to All CHARLOTTE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- On Monday, , the premium supplement brand co-founded by , hosted IM8 Vibrante - A Celebration of Science, Wellness & Flavor, a memorable evening at the iconic on Miami Beach. In attendance were nearly 150 wellness influencers, creators, science and medical advisors, and media members to celebrate...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch